ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

In Brief: John Minton Dies Forom Auto Accident Injuries; FDA Rules Against Generic Megastrol Acetate

January 11, 1991

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

Study Disproves “Old Saw,” Finds Life No Worse for Cancer Patients

December 3, 1982

NCAB Gives Final Approval to New Guidelines for P01s

May 29, 1987

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991